Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Research Article May 25 2023
Small gene networks delineate immune cell states and characterize immunotherapy response in melanoma
Cancer Immunol Res CIR-22-0563.
Research Article May 25 2023
Systemic Alterations in Type-2 Conventional Dendritic Cells Leads to Impaired Tumor Immunity in Pancreatic Cancer
Cancer Immunol Res CIR-21-0946.
Priority Brief May 22 2023
T cell–mediated development of stromal fibroblasts with an immune-enhancing chemokine profile
Cancer Immunol Res CIR-22-0593.
Research Article May 22 2023
CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
Cancer Immunol Res CIR-22-0406.
Research Article May 18 2023
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2
Cancer Immunol Res (2023)
Research Article May 18 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity
Cancer Immunol Res (2023)
Research Article May 18 2023
IL12/18/21 Preactivation Enhances the Antitumor Efficacy of Expanded γδT Cells and Overcomes Resistance to Anti–PD-L1 Treatment
Cancer Immunol Res (2023)
Research Article May 12 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-In-Human Clinical Trial in Patients with Advanced Metastatic Cancer
Cancer Immunol Res CIR-22-0444.
Research Article May 12 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses
Cancer Immunol Res (2023)
Research Article May 12 2023
iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration
Cancer Immunol Res (2023)
In the Spotlight May 12 2023
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status
Cancer Immunol Res (2023)
Research Article May 10 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Cancer Immunol Res CIR-22-0961.
Research Article May 5 2023
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy
Cancer Immunol Res (2023)
In the Spotlight May 5 2023
Linking Body Composition and Nutritional Status with CAR T-cell Efficacy
Cancer Immunol Res (2023)
Research Article May 4 2023
Breast Cancer Stem Cell–Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands
Cancer Immunol Res (2023)
Research Article May 2 2023
KRT17 promotes T-lymphocyte infiltration through the YTHDF2-CXCL10 axis in colorectal cancer
Cancer Immunol Res CIR-22-0814.
Research Article May 2 2023
NL-201 upregulates MHC-I expression and intratumoral TCR diversity, and demonstrates robust antitumor activity as monotherapy and in combination with PD-1 blockade
Cancer Immunol Res CIR-22-0304.
Research Article May 2 2023
The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
Cancer Immunol Res (2023)
Research Article May 2 2023
Clonal Spreading of Tumor-Infiltrating T Cells Underlies the Robust Antitumor Immune Responses
Cancer Immunol Res (2023)
Research Article April 27 2023
EBV-Upregulated B7-H3 Inhibits NK cell–Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression
Cancer Immunol Res (2023)
Research Article April 27 2023
Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
Cancer Immunol Res (2023)
Research Article April 18 2023
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors
Cancer Immunol Res (2023)
Research Article April 16 2023
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects
Cancer Immunol Res (2023)
Research Article April 14 2023
Regional variation in the tumor microenvironment, immune escape and prognostic factors in breast cancer in sub-Saharan Africa
Cancer Immunol Res CIR-22-0795.
Close Modal

or Create an Account

Close Modal
Close Modal